Deutsche Bank Ag\ Codexis, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Codexis, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 35,134 shares of CDXS stock, worth $138,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,134

Previous 25,052 40.24%

Holding current value

$138,076

Previous $77,000 40.26%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.62 - $3.71 $26,414 - $37,404	10,082 Added 40.24%	35,134 $108,000
Q2 2024 Aug 14, 2024	SELL	$2.65 - $3.92 $18,905 - $27,965	-7,134 Reduced 22.16%	25,052 $77,000
Q1 2024 May 15, 2024	SELL	$2.59 - $4.65 $42,033 - $75,464	-16,229 Reduced 33.52%	32,186 $112,000
Q4 2023 Feb 14, 2024	BUY	$1.54 - $3.37 $71,477 - $156,415	46,414 Added 2319.54%	48,415 $147,000
Q3 2023 Nov 09, 2023	SELL	$1.5 - $3.75 $36,945 - $92,362	-24,630 Reduced 92.49%	2,001 $3,000
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.43 $28,352 - $56,832	-12,829 Reduced 32.51%	26,631 $74,000
Q1 2023 May 15, 2023	BUY	$3.81 - $6.76 $46,920 - $83,249	12,315 Added 45.37%	39,460 $163,000
Q4 2022 Feb 13, 2023	BUY	$4.26 - $6.84 $1,738 - $2,790	408 Added 1.53%	27,145 $126,000
Q3 2022 Nov 14, 2022	SELL	$6.06 - $12.86 $46,328 - $98,314	-7,645 Reduced 22.24%	26,737 $162,000
Q2 2022 Aug 11, 2022	SELL	$8.35 - $21.89 $21,476 - $56,301	-2,572 Reduced 6.96%	34,382 $360,000
Q1 2022 May 13, 2022	SELL	$16.97 - $31.93 $87,412 - $164,471	-5,151 Reduced 12.23%	36,954 $762,000
Q4 2021 Feb 11, 2022	SELL	$25.61 - $41.78 $220,399 - $359,558	-8,606 Reduced 16.97%	42,105 $1.32 Million
Q3 2021 Nov 04, 2021	SELL	$19.65 - $27.99 $1.31 Million - $1.86 Million	-66,512 Reduced 56.74%	50,711 $1.18 Million
Q2 2021 Aug 11, 2021	SELL	$17.48 - $25.46 $586,821 - $854,717	-33,571 Reduced 22.26%	117,223 $2.66 Million
Q1 2021 May 13, 2021	BUY	$18.08 - $28.8 $1.85 Million - $2.95 Million	102,446 Added 211.89%	150,794 $3.45 Million
Q4 2020 Feb 16, 2021	SELL	$11.7 - $23.41 $1.29 Million - $2.59 Million	-110,599 Reduced 69.58%	48,348 $1.06 Million
Q3 2020 Nov 12, 2020	SELL	$11.21 - $13.82 $209,716 - $258,544	-18,708 Reduced 10.53%	158,947 $1.87 Million
Q2 2020 Aug 13, 2020	BUY	$9.8 - $12.77 $1.53 Million - $1.99 Million	155,858 Added 715.04%	177,655 $2.03 Million
Q1 2020 May 14, 2020	BUY	$8.78 - $18.6 $21,159 - $44,826	2,410 Added 12.43%	21,797 $243,000
Q4 2019 Feb 14, 2020	SELL	$13.12 - $17.06 $248,663 - $323,338	-18,953 Reduced 49.43%	19,387 $309,000
Q3 2019 Nov 14, 2019	SELL	$12.75 - $19.01 $212,721 - $317,162	-16,684 Reduced 30.32%	38,340 $524,000
Q2 2019 Aug 14, 2019	SELL	$17.0 - $21.88 $503,421 - $647,932	-29,613 Reduced 34.99%	55,024 $1.01 Million
Q1 2019 May 15, 2019	BUY	$15.53 - $22.15 $249,225 - $355,463	16,048 Added 23.4%	84,637 $1.74 Million
Q4 2018 Feb 14, 2019	SELL	$14.06 - $22.57 $809,321 - $1.3 Million	-57,562 Reduced 45.63%	68,589 $1.14 Million
Q3 2018 Dec 21, 2021	BUY	$13.35 - $19.1 $322,722 - $461,723	24,174 Added 23.71%	126,151 $2.16 Million
Q3 2018 Nov 14, 2018	BUY	$13.35 - $19.1 $22,868 - $32,718	1,713 Added 1.71%	101,977 $1.75 Million
Q2 2018 Apr 21, 2020	BUY	$10.35 - $16.45 $193,710 - $307,878	18,716 Added 22.95%	100,264 $1.44 Million
Q2 2018 Aug 14, 2018	BUY	$10.35 - $16.45 $108,447 - $172,363	10,478 Added 14.74%	81,548 $1.17 Million
Q1 2018 Oct 18, 2019	BUY	$8.0 - $12.8 $76,328 - $122,124	9,541 Added 15.51%	71,070 $780,000
Q1 2018 May 15, 2018	SELL	$8.0 - $12.8 $364,480 - $583,168	-45,560 Reduced 42.54%	61,529 $675,000
Q4 2017 Feb 14, 2018	BUY	$5.85 - $8.4 $251,286 - $360,822	42,955 Added 66.98%	107,089 $890,000
Q3 2017 Nov 14, 2017	BUY	$4.9 - $6.65 $314,256 - $426,491	64,134	64,134 $423,000

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

59.9M

Call Options Held

25.9K

Put Options Held

20.1K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $257M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account